1999
DOI: 10.1016/s0090-4295(99)00058-8
|View full text |Cite
|
Sign up to set email alerts
|

A new temporary catheter (ContiCath) for the treatment of temporary, reversible, postoperative urinary retention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2000
2000
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…Several "intraurethral catheters" have been developed for treatment of benign prostatic hypertrophy or for temporary placement after minimally invasive prostate surgery as an alternative to standard Foley catheters [11][12][13][14][15]. These catheters share common features with the Surinate; they extend from the bladder neck to the proximal urethra and have retention designs to prevent migration.…”
Section: Discussionmentioning
confidence: 99%
“…Several "intraurethral catheters" have been developed for treatment of benign prostatic hypertrophy or for temporary placement after minimally invasive prostate surgery as an alternative to standard Foley catheters [11][12][13][14][15]. These catheters share common features with the Surinate; they extend from the bladder neck to the proximal urethra and have retention designs to prevent migration.…”
Section: Discussionmentioning
confidence: 99%
“…Corujo et al20 described the use of the ContiCath in the management of postoperative and temporary BOO. These authors used 3 groups of patients for their study: patients with nonneurogenic causes of retention and retention less than 1 week (37 patients), patients with nonneurogenic causes of retention and retention longer than 1 week (19 patients), and patients with neurogenic causes of retention (eg, diabetes mellitus) and retention longer than 1 week (5 patients).…”
Section: Temporary Stentsmentioning
confidence: 99%
“…Patients sustaining a stroke in the frontoparietal cortex or the internal capsule are even more susceptible to development of bladder hyperreflexia (Burney et al, 1996). Conservative management of bladder dysfunction after stroke involves catheterization and anticholinergic drug treatment, but both of these treatments have a significant risk of side effects, such as urinary tract infections and urinary retention (Corujo et al, 1999). Development of novel therapies is impeded by a lack of reproducible animal models of bladder hyperreflexia.…”
Section: Introductionmentioning
confidence: 99%